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Abstract
Enterococci have been considered as one of the most common causes of nosocomial infections. The spread of antibiotic resistance has 
posed a serious challenge to treating the enterococcal infections. High-level aminoglycosides resistance leads to failure in the synergistic 
combination therapy. 
This study aimed to estimate the prevalence of high-level gentamicin resistance (HLGR) among clinical isolates of enterococci in Iran.
Systematic literature search was conducted in the Web of Science, PubMed, Scopus and Google Scholar electronic databases from ar-
ticles which were published from April 2000 to September 2018. Literature search yielded 918 studies. Eligible studies were selected ac-
cording to the defined inclusion and exclusion criteria. Statistical heterogeneity was estimated by Q statistic and the I2 index. The Begg’s 
rank correlation test and Egger’s weighted regression tests were used to evaluate possible publication bias.
Nineteen studies were included in this review. According to the meta-analysis results, the prevalence of HLGR among Enterococcus spp. 
was 49.4% (95% CI: 42.2%-56.6%). It was estimated 44.3% (95% CI: 38.1%-50.8%) and 66.3% (95% CI: 51.4%-78.6%) for E. faecalis and 
E. faecium, respectively.
Since notable rate of HLGR in enterococci was seen in this analysis, improving the implementation of all aspects of the infection control 
programmes is required. Accurate and regular monitoring of infection control procedures are necessary for reducing the dissemination 
of such infections.
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INTRODUCTION
Enterococci are common inhabitants of the human gastroin-
testinal tract and they are known to be potent pathogens 
responsible for several infections in humans.1 Enterococci 
have been considered as one of the most common causes 
of nosocomial infections worldwide.2 The spread of anti-
biotic resistance has posed a serious challenge to the tre-
atment of the enterococcal infections.3 Simultaneous pre-
scription of aminoglycosides and cell wall active agents 
(such as β-lactams or vancomycin) will be synergistically 
effective against severe infections.4 In 1979, high-level 
aminoglycosides resistance in enterococci was initially 
described in the US.5 High-level resistance (HLR) to the ami-
noglycosides leads to failure in the synergistic combination 
therapy.4,6 Moreover, horizontal HLR associated genes 
transfer is common between various strains and it can in-
crease the risk of the development and dissemination of 
such resistance in enterococci.7 
According to available data, the prevalence rates of 
high-level gentamicin resistance (HLGR) in enterococci 
have been reported from several parts of Iran.1,8-11 How-
ever, there is no comprehensive analysis regarding HLGR 
amongst Enterococcus isolates, obtained from several in-
fections in the country. Therefore, the aim of the present 
study was to assess the prevalence of HLGR among clinical 
isolates of enterococci in Iran using a systematic review and 
meta-analysis conforms to the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses.
MATERIALS AND METHODS
Search strategies
A systematic literature search was conducted in the Web of 
Science, PubMed, Scopus, and Google Scholar electronic 
databases from papers that were published from April 2000 
to September 2018 following the PRISMA (the Preferred 
Reporting Items for Systematic Reviews and Meta-Analy-
ses) guidelines. The following keywords, “Enterococcus” or 
“E. faecalis” or E. faecium and “high level aminoglycoside 
resistant” or “high level gentamicin resistant” or “HLGR” in 
combination with “Iran” were searched as scientific terms 
in the present survey. We also searched bibliographies of 
retrieved articles for additional references.
Eligibility criteria and study selection
Cross-sectional or cohort studies that reported the pre-
valence of HLGR in Iran were considered. To determi-
ne the articles which had inclusion criteria, the titles, 
abstracts and full texts were screened independently by two 
reviewers and any discrepancies were resolved by consen-
sus. The articles published in English or Persian language 
which were indexed in PubMed or Scopus with the follo-
wing characteristics were included: standard used methods 
for HLGR detection in Enterococcus strains and reported 
data on number of HLGR among Enterococcus strains. 
According to the Clinical and Laboratory Standards Insti-
tute (CLSI) guidelines12, standard methods for detecting 
HLGR among Enterococcus strains are broth dilution, agar 
dilution, and disk diffusion methods by high-content gen-
tamicin (120 µg). Additionally, research that has been con-
ducted by non-Iranian authors on the Iranian population 
or samples were also assessed. Studies with nonstandard 
methods and without report of HLGR prevalence were 
excluded. We also excluded studies which their sample 
size was less than 10 isolates, nonhuman studies, review 
articles, meta-analyses or systematic reviews, congress 
abstracts and duplicate publication of the same studies.
Data extraction and definitions
Data collection was performed in parallel by two authors 
and discrepancies were resolved by a third author. Data col-
lected included: first author’s name, the study performing 
time, publication date, the study setting, sample size (num-
ber of Enterococcus, E. faecalis and E. faecium isolates) and 
prevalence of HLGR.
Statistical analysis
Analysis of data was performed by Comprehensive Me-
ta-Analysis Software v. 2.2 (Bio stat Company). Meta-ana-
lysis was performed using random effects model to estima-
te pooled prevalence and corresponding 95% confidence 
interval (CI). Statistical heterogeneity between and within 
groups was estimated by the Q statistic and the I2 index. 
The Begg’s rank correlation test and Egger’s weighted re-
gression tests were used to evaluate possible publication 
bias (p<0.05 was considered indicative of a statistically 
significant publication bias).
RESULTS
The literature search yielded 918 studies, 856 were exclu-
ded based on their index and review of title and abstract, 
leaving 62 articles for full text review. Of 62 reviewed stu-
dies, HLGR was not detected in 22 studies according to the 
standard methods, 12 studies did not report the prevalence 
of Enterococcus or Enterococcus spp., 4 studies had sample 
size less than 10 isolates, and the results of 5 studies were 
unclear. Eventually, 19 eligible studies were chosen for final 
analysis. There were no overlapping study populations in 
the final review. Fig. 1 shows the study selection process 
and reasons for exclusion. None of the included studies 
received direct funding from pharmaceutical companies. 
The full results of included articles, the prevalence of E. fae-
calis and E. faecium and the frequency of HLGR amongst 
them are presented in Table 1. 
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standard methods for HLGR 
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● Studies that did not report the 
prevalence of Enterococcus spp.
(n = 12)
● Studies that had unclear results
(n = 5)
Nineteen studies investigated the frequency of HLGR 
among Enterococcus spp. The pooled prevalence for HLGR 
among Enterococcus isolates was 49.4% (95% CI: 42.2%-
56.6%) ranging from 15% to 96% (Fig. 2). There was a sig-
nificant heterogeneity among the 19 studies (χ2=301.393; 
p<0.001; I2=94%). Additionally, Begg’s and Egger’s tests 
were performed to quantitatively evaluate the publicati-
on biases. The results of Begg’s test (z=0.42, p=0.67) and 
Egger’s test (t=0.54, p=0.6) showed no evidence of publi-
cation bias. 
According to the included publications, in 15 studies the 
frequency of HLGR in E. faecalis strains was investigated. 
The pooled prevalence of HLGR among E. faecalis isolates 
was 44.3% (95% CI: 38.1%-50.8%) ranging from 24% to 
65% (Fig. 3). There was a significant heterogeneity among 
the 15 studies (χ2=111.703; p<0.001; I2=87.47%). There was 
no evidence of publication bias according to Begg’s rank 
correlation analysis (z=0.1, p=0.92). Egger’s regression ana-
lysis also confirmed there is no evidence of publication bias 
(t=1.08, p=0.3). 
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Table 1. Characteristics of studies included in the meta-analysis 
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We found 10 articles which investigated the frequency 
of HLGR in E. faecium isolates (one study was excluded 
because the sample size for E. faecium was less than ten). 
The pooled prevalence of HLGR in E. faecium isolates was 
66.3% (95% CI: 51.4%-78.6%) ranging from 24% to 96% 
(Fig. 4). Based on Q statistic and the I2 index, heterogen-
eity was significant (χ2=100.387; p<0.001; I2=91%). Also, 
the Begg’s rank correlation analysis (z=1.25, p=0.21) and 
Egger’s regression analysis (t=1.2, p=0.26) confirmed no 
evidence of publication bias.
DISCUSSION
To the best of our knowledge, this study is the first syste-
matic review regarding the prevalence of HLGR amongst 
HLGR among enterococci in Iran
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Figure 2. Forest plot of prevalence of HLGR among Enterococcus spp. in Iran.
Figure 3. Forest plot of prevalence of HLGR among E. faecalis isolates in Iran.
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enterococci that caused several infections in Iran. Accor-
ding to the meta-analysis results, the pooled prevalence of 
high-level gentamicin resistant Enterococcus isolates was 
49.4% (95% CI: 42.2%-56.6%). The prevalence of HLGR in 
Enterococcus in Iran is more than the one reported in a pre-
vious investigation in a neighbor country, Kuwait (14%).27 
However, high rates of HLGR in enterococcal bacteremia 
have been described in industrialized countries such as 
Korea (63%) and Spain (60.4%).28,29 
Our results indicated that the pooled prevalence of 
high-level gentamicin resistant E. faecalis isolates was 
44.3% (95% CI: 38.1%-50.8%). More rates have been re-
ported from Saudi Arabia (75.3%) and Taiwan (60%).30,31 
The prevalence of HLGR in E. faecalis in Iran was more 
than that in other countries such as Japan (34.2%), Turkey 
(30%), Kuwait (14.7%), and USA (15%).27,32-34 Neverthe-
less, notable HLGR prevalence of bacteremia causative 
E. faecalis strains has been reported from Spain (62.9%), 
China (40.9%), Denmark (38.2%), New Zealand (38%), 
and Japan (32%).29,35-38 
Based on the meta-analysis results, the pooled preva-
lence of HLGR in E. faecium isolates was 66.3% (95% CI: 
51.4%-78.6%) in Iran. It is more than the prevalence in two 
other Asian countries such as Kuwait (15.6%) and Japan 
(9.2%).27,32 Also, higher rates of HLGR in E. faecium (Up 
to 88%) has been described in Turkey.33 However, high 
prevalence of high-level gentamicin resistant E. faecium 
isolated from blood stream was reported from developed 
countries such as Canada (71.6%), Denmark (64.4%), and 
Spain (53.8%).29,35,39 It was lower for China (43.2%), New 
Zealand (25%), and Japan (24%).36-38 The mentioned data, 
suggested that high-level gentamicin resistant strains pos-
sess significant ability to cause invasive infections such as 
blood stream infection.
Prevalence of resistant enterococcal strains amongst pa-
tients may be due to several factors; recently, various studies 
described the effects of diet on gut microbiota composition. 
Special diet such as fiber (as a non-digestible carbohydra-
te) consumption change Enterococcus species population in 
gastrointestinal tract.40,41 Also, drug-resistant Enterococcus 
isolates of animal origin can easily contaminate the food 
chain and infect humans and affect the intestinal coloni-
zation.42,43 Hospitalization of colonized patients by such 
strains may lead to dissemination of drug-resistant strains 
in hospital environment and among patients. Therefore, di-
verse ranges of high-level gentamicin resistant enterococ-
ci isolated from hospitalized patients in various countries 
may be related to their diverse dietary habits.
Enterococci are able to survive under environmental 
stresses such as dryness and selective antimicrobial pressu-
re. Therefore, hospital setting has an important role in the 
spread of resistant strains among patients and high-quality 
disinfection and cleaning of all surfaces and medical equip-
ment are necessary.44-46 Inadequate efficacy of utilized dis-
infectant due to reduced biocide sensitivity in enterococci 
may be one of the major issues in the infection control im-
plementation in hospitals.
In addition, unfavourable condition may induce via-
ble-but-nonculturable (VBNC) strains.44 This pheno-
menon can lead to transmission of resistant strains among 
patients, despite the effective appearance of the infection 
control policies.
Emergence of drug-resistant bacteria has accelerated 
by overuse and misuse of antibiotics.47,48 Ineffective ami-
Figure 4. Forest plot of prevalence of HLGR among E. faecium isolates in Iran.
HLGR among enterococci in Iran
21Folia Medica I 2021 I Vol. 63 I No. 1
noglycosides prescription may contribute to selection of 
high-level gentamicin resistant strains. Colonization and 
dissemination of selected strains in hospital enhance the 
prevalence of HLGR among hospitalized patients.
HLGR in enterococci often occurs through acquisition 
of aph(2’’)-Ia-aac(6’)-Ie gene.7 This bifunctional gene is 
most commonly located on a transposon. Therefore, hori-
zontal gene exchange and acquired HLR traits will occur 
quickly among colonized Enterococcus spp. Other HLGR 
encoding genes are most frequently in E. faecium.7 It can 
explain the greater prevalence of HLGR among E. faecium 
strains.
Considering the mentioned features of enterococci, 
it seems that the most effective strategy among the many 
possible strategies for reducing the transmission of health-
care-associated infections, is hand hygiene compliance 
amongst healthcare workers. As mentioned in a previous 
systematic review in Iran, training of healthcare workers 
seems to be necessary for prevention and control of noso-
comial infections.49 
There are some limitations to the present review. First, 
only the published articles which were indexed in PubMed 
or Scopus were included in this meta-analysis. Secondly, 
few studies had been performed in different region of the 
country and most of the evaluated articles were related to 
Tehran (the capital of Iran).
CONCLUSIONS 
The present systematic review indicates notable prevalence 
of high-level resistance to gentamicin amongst Enterococ-
cus species in Iranian patients. According to the papers pu-
blished from April 2000 to September 2018, diverse ranges 
were reported from Iran. This comprehensive analysis sho-
wed that, the prevalence of high-level gentamicin resistant 
Enterococcus spp. was 49.4%. Also, the prevalence of HLGR 
in E. faecium strains was greater than that in E. faecalis. 
Therefore, improving the implementation of all aspects of 
the infection control programs according to the internatio-
nal standards is necessary.
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Резюме
Enterococci считаются одной из наиболее частых причин внутрибольничных инфекций. Высокая устойчивость к аминоглико-
зидам приводит к недостаточности синергетической комбинированной терапии.
Целью этого исследования было оценить частоту высокой устойчивости к гентамицину (HLGR) среди клинических изолятов 
энтерококков в Иране.
Был проведён систематический обзор литературы в электронных базах данных Web of Science, PubMed, Scopus и Google 
Scholar на предмет поиска статей, опубликованных с апреля 2000 г. по сентябрь 2018 г. Поиск в доступной литературе выявил 
918 исследований. Подходящие исследования были отобраны в соответствии с заранее определенными критериями включе-
ния и исключения. Статистическая неоднородность измерялась Q-статистикой и индексом I2. Для оценки возможной субъек-
тивности публикаций использовались тест ранговой корреляции Бегга и регрессионный тест Эгера.
В этот обзор было включено девятнадцать исследований. По результатам метаанализа частота HLGR к Enterococcus spp. 
составила 49.4% (95% CI: 42.2% -56.6%). Результаты показали 44.3% (95% CI: 38.1% –50.8%) и 66.3% (95% CI: 51.4% –78.6%) для 
E. faecalis и E. faecium, соответственно.
Поскольку в ходе этого анализа была обнаружена высокая частота HLGR в отношении enterococci, мы пришли к выводу, что 
необходимо улучшить все аспекты процедур инфекционного контроля, чтобы уменьшить распространение таких инфекций.
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